423 related articles for article (PubMed ID: 18006846)
21. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
22. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
[TBL] [Abstract][Full Text] [Related]
23. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
24. miR-27a regulates endothelial differentiation of breast cancer stem like cells.
Tang W; Yu F; Yao H; Cui X; Jiao Y; Lin L; Chen J; Yin D; Song E; Liu Q
Oncogene; 2014 May; 33(20):2629-38. PubMed ID: 23752185
[TBL] [Abstract][Full Text] [Related]
25. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
27. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.
Banerjee N; Talcott S; Safe S; Mertens-Talcott SU
Breast Cancer Res Treat; 2012 Nov; 136(1):21-34. PubMed ID: 22941571
[TBL] [Abstract][Full Text] [Related]
29. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.
Liu B; Peng XC; Zheng XL; Wang J; Qin YW
Lung Cancer; 2009 Nov; 66(2):169-75. PubMed ID: 19223090
[TBL] [Abstract][Full Text] [Related]
30. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells.
Choi EJ; Kim GH
Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420
[TBL] [Abstract][Full Text] [Related]
31. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
32. Rapid alteration of microRNA levels by histone deacetylase inhibition.
Scott GK; Mattie MD; Berger CE; Benz SC; Benz CC
Cancer Res; 2006 Feb; 66(3):1277-81. PubMed ID: 16452179
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
[TBL] [Abstract][Full Text] [Related]
34. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
35. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
Harper J; Yan L; Loureiro RM; Wu I; Fang J; D'Amore PA; Moses MA
Cancer Res; 2007 Sep; 67(18):8736-41. PubMed ID: 17875714
[TBL] [Abstract][Full Text] [Related]
36. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
[TBL] [Abstract][Full Text] [Related]
37. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
39. GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells.
Cazet A; Groux-Degroote S; Teylaert B; Kwon KM; Lehoux S; Slomianny C; Kim CH; Le Bourhis X; Delannoy P
Biol Chem; 2009 Jul; 390(7):601-9. PubMed ID: 19335207
[TBL] [Abstract][Full Text] [Related]
40. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
Ma Y; Yu S; Zhao W; Lu Z; Chen J
Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
